Family Management’s AbbVie ABBV Stock Holding History

Family Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.04M	Buy	4,143 +248	+6%	+$53.4K	0.11%	124
2026 Q1	$847K	Buy	3,895 +425	+12%	+$94.3K	0.1%	116
2025 Q4	$793K	Buy	3,470 +850	+32%	+$194K	0.1%	105
2025 Q3	$607K	Buy	2,620 +817	+45%	+$166K	0.08%	116
2025 Q2	$335K	Buy	1,803 +685	+61%	+$127K	0.05%	146
2025 Q1	$234K	Buy	+1,118	New	+$217K	0.04%	160
2016 Q4	–	Sell	-111,278	Closed	-$7.02M	–	70
2016 Q3	$7.02M	Sell	111,278 -2,475	-2%	-$160K	3.97%	4
2016 Q2	$7.04M	Sell	113,753 -1,950	-2%	-$119K	3.99%	6
2016 Q1	$6.61M	Sell	115,703 -3,250	-3%	-$181K	4.29%	5
2015 Q4	$7.05M	Buy	118,953 +3,478	+3%	+$200K	3.64%	9
2015 Q3	$6.28M	Buy	115,475 +15,425	+15%	+$1M	2.77%	13
2015 Q2	$6.72M	Buy	100,050 +7,350	+8%	+$480K	2.77%	10
2015 Q1	$5.43M	Buy	+92,700	New	+$5.6M	2.5%	13

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Family Management's ABBV Position: Q2 2026 in Review

Family Management increased its AbbVie (ABBV) stake by 6.4% in Q2 2026, buying an estimated $53.4K and bringing the position to 4,143 shares worth $1.04M. The position accounts for 0.11% of the portfolio, ranked #124.

Family Management first reported a position in ABBV in Q1 2015 and has held it in 13 quarters since. The position peaked at $7.05M in Q4 2015. 4,209 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Family Management held 4,143 shares of AbbVie worth $1.04M as of Q2 2026.
Family Management bought 248 AbbVie shares in Q2 2026, an estimated $53.4K.
AbbVie made up 0.11% of Family Management's portfolio in Q2 2026, its #124 holding.
Family Management first reported a position in AbbVie in Q1 2015 and has held it in 13 quarters since.
Family Management's AbbVie position peaked at $7.05M in Q4 2015.
4,209 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Family Management's 13F filing for Q2 2026, filed 14 Aug 2026.